High Intake Of Cow Milk Products Increases Risk Of Type 1 Diabetes In Kids: Study
- byDoctor News Daily Team
- 24 July, 2025
- 0 Comments
- 0 Mins
Finland: High consumption of cow milk products increases the risk of prediabetes associated with type 1 diabetes in children, according to a study conducted in Finland.
In addition, the researchers also investigated the link between cow's milk products and the development of asthma in children. The study found that the consumption of milk products subjected to high-temperature treatment, such as infant formula, was associated with a heightened risk of developing asthma.
Katariina Koivusaari, Master of Food Sciences at the University of Helsinki, observed in her doctoral research carried out at the Finnish Institute for Health and Welfare that high consumption of cow's milk products was linked to a heightened risk of developing type 1 diabetes in children who were genetically predisposed to the disease.
Type 1 diabetes is more common among children in Finland than anywhere else in the world, and its incidence has multiplied manyfold since the 1950s.
"In terms of composition, milk is a very complex substance, and the factors in milk that may be associated with risk of diseases cannot be pinpointed on the basis of the research conducted so far," Koivusaari says.
That high consumption of milk in early childhood may potentially predispose people to type 1 diabetes has already been observed in prior studies.
A link between infant formula and asthma in children?
In addition to type 1 diabetes, Koivusaari investigated the link between cow's milk products and the development of asthma in children. The study found that the consumption of milk products subjected to high-temperature treatment, such as infant formula, was associated with a heightened risk of developing asthma. A corresponding link was not observed in pasteurized milk products, in which case the treatment is less intense. The findings indicate that the processing of milk may alter its immunological properties.
With regard to asthma, prior research has provided indications of raw, unprocessed milk potentially protecting children against asthma. However, raw milk cannot be recommended for children, as it may contain hazardous bacteria. Koivusaari's doctoral thesis is the first study observing a possible link between the high consumption of milk products subjected to high-temperature treatment, which includes infant formula, and a heightened risk of developing asthma in children.
According to Koivusaari, further research is needed to understand whether the consumption of cow's milk products actually predisposes to preclinical type 1 diabetes and that of infant formulas to asthma. It may also be that the explanation for the links observed is a factor that is yet to be identified.
"Further studies should also determine which factor in milk may be connected to the risk of diseases for this to be taken into account in its processing. Individual research findings do not change nutritional recommendations, which are based on extensive research evidence," Koivusaari notes.
The dataset
The dataset utilized in Koivusaari's doctoral thesis is based on the Type 1 Diabetes Prediction and Prevention (DIPP) study, which includes more than 6,000 children born between 1996 and 2004 in the university hospitals of Tampere and Oulu.
In the study, data on the children's diets were collected with the help of food records. Cow's milk products were classified according to the adopted heat treatment and homogenization. At intervals of 3–12 months, the study participants were monitored for the occurrence in blood samples of type 1 diabetes-related autoantibodies, which indicate prediabetes, and information on asthma was collected when the children were five.
Reference:
The study titled, "Consumption of differently processed milk products and the risk of asthma in children," was published in the journal Pediatric Allergy and Immunology.
DOI: https://onlinelibrary.wiley.com/doi/10.1111/pai.13659
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!